1. Home
  2. TECX vs BNTC Comparison

TECX vs BNTC Comparison

Compare TECX & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$19.63

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$11.26

Market Cap

405.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
BNTC
Founded
2019
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
359.0M
405.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
BNTC
Price
$19.63
$11.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$81.20
$28.25
AVG Volume (30 Days)
350.0K
243.3K
Earning Date
11-06-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$9.70
52 Week High
$61.07
$17.15

Technical Indicators

Market Signals
Indicator
TECX
BNTC
Relative Strength Index (RSI) 52.23 39.57
Support Level $17.79 $9.93
Resistance Level $19.12 $12.99
Average True Range (ATR) 1.43 1.00
MACD -0.22 -0.11
Stochastic Oscillator 48.25 41.60

Price Performance

Historical Comparison
TECX
BNTC

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: